The premier Asia-Pacific biopharma conference for global cross-border partnerships
The Asia Bio Partnering Forum program is developed to highlight the powerful rise of innovation in the Asia-Pacific life science market.
Asia Bio Partnering Forum: Shaping the Future of APAC Biotech
Asia Bio Partnering Forum is where the future of biotech, pharma, and investment converges. Designed to connect global stakeholders with Asia's dynamic life sciences ecosystem, this high-impact forum fosters dealmaking, investment, and collaboration among key players driving the next wave of innovation.
Investment & Deal-Making
Gain insights from top investors and industry leaders on funding strategies, M&A trends, and the evolving biotech landscape in Asia.
R&D & Innovation
Explore cutting-edge advancements in AI-driven drug discovery, next-gen therapeutics, and breakthrough technologies shaping the future of healthcare.
Market Access & Collaboration
Navigate regulatory challenges, cross-border collaborations, and strategies for taking Asian biotech innovation to the world stage.
Startup Spotlight
Witness the most promising biotech startups pitch live in front of industry leaders and investors.
BioSyndicate: Asia Bio Partnering Forum Investor Workshop
Key Information
🔹 Date: Monday 31 August, 2026 (Preceding Asia Bio Partnering Forum)
🕐 Time: 1:00pm – 5:00pm (Drinks Reception to Follow)
📍 Location: Singapore (TBC)
Exclusive Investor-Only Workshop on August 31 focused on syndication strategies in the Asian biotech landscape
Pre-conference session providing valuable insights into:
• Biotech investment & syndication
• Medtech investment & syndication
Attendees will engage with thought leaders in panel discussions covering the next wave of biotech investment in Asia, practical syndication strategies, and future market predictions.
Event culminates with a networking reception, offering valuable opportunities to connect with potential investment partners.
Perfect for investors seeking to understand cross-border funding collaborations, de-risking strategies, and emerging trends in the Asian biotech ecosystem.
Focused on syndication strategies in biotech and medtech investment.
Asia Bio Partnering Forum / Medtech joint program sessions
Preview for program sessions for Day 1.
Asia Bio Partnering Forum Plenary Sessions
- Partnering with Big Pharma in a Risk-Off Market
- China, Japan & ASEAN Deal Flow in 2026: Where Are the Real Opportunities?
- From Discovery to Deal: What Global Pharma Wants in 2026
- Funding After the Reset: New Valuations, New Terms, New Power Dynamics
- Startup Spotlight Startup Spotlight
Medtech Symposium
- Spotlight on Medtech in the Asia Pacific: Opportunities, Challenges, and the Path Forward
- Unlocking Strategic Partnerships: How to Engage Tier 1 Medtech and Pharma’s Biggest Players
- Attracting Investment from Family Offices as a Medtech or Digital Health Startup
- What’s Hot in Medtech? (Ageing, Diagnostics, Neuro & Robotics)
Day 2 program preview
Discover the program for the Asia Bio Partnering Forum and Medtech program sessions day 2.
Asia Bio Partnering Forum program day 2
- US-China-Europe: Managing Political & Commercial Risk
- The New Exit Landscape: M&A, IPOs & Strategic Acquisitions
- Structuring Cross-Border Deals in a Fragmented Regulatory World
- Closing Fireside: Building the Asia Pacific’s Next Biotech Champions
- Harmonizing Medtech Regulations in the Asia Pacific: Feasibility, Timelines, and Progress
- Scaling in the US
- Scaling in EMEA
- AI as The Star of the Show – Spotlight on AI Funding Trends, ROI & Scaling
2025 - Advisory board
Meet our distinguished Advisory Board - industry leaders and innovators shaping the future of biotech in Asia-Pacific. Their collective expertise spans biotech, pharmaceuticals, investment, and strategic partnerships, ensuring our program delivers cutting-edge insights and meaningful connections for the life sciences community. These thought leaders guide our mission to foster cross-border collaboration and accelerate innovation across the region's dynamic biotech ecosystem.






